BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9425291)

  • 1. Role of E boxes in the repression of E-cadherin expression.
    Giroldi LA; Bringuier PP; de Weijert M; Jansen C; van Bokhoven A; Schalken JA
    Biochem Biophys Res Commun; 1997 Dec; 241(2):453-8. PubMed ID: 9425291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extinction of E-cadherin expression in breast cancer via a dominant repression pathway acting on proximal promoter elements.
    Hajra KM; Ji X; Fearon ER
    Oncogene; 1999 Dec; 18(51):7274-9. PubMed ID: 10602481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of E-cadherin gene expression during tumor progression: the role of a new Ets-binding site and the E-pal element.
    Rodrigo I; Cato AC; Cano A
    Exp Cell Res; 1999 May; 248(2):358-71. PubMed ID: 10222128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progression of carcinoma cells is associated with alterations in chromatin structure and factor binding at the E-cadherin promoter in vivo.
    Hennig G; Behrens J; Truss M; Frisch S; Reichmann E; Birchmeier W
    Oncogene; 1995 Aug; 11(3):475-84. PubMed ID: 7630631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sp1/Sp3 and the myeloid zinc finger gene MZF1 regulate the human N-cadherin promoter in osteoblasts.
    Le Mée S; Fromigué O; Marie PJ
    Exp Cell Res; 2005 Jan; 302(1):129-42. PubMed ID: 15541732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation and initial characterization of the BRCA2 promoter.
    Davis PL; Miron A; Andersen LM; Iglehart JD; Marks JR
    Oncogene; 1999 Oct; 18(44):6000-12. PubMed ID: 10557089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoter methylation regulates cadherin switching in squamous cell carcinoma.
    Chen Q; Lipkina G; Song Q; Kramer RH
    Biochem Biophys Res Commun; 2004 Mar; 315(4):850-6. PubMed ID: 14985090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells.
    Braunstein I; Cohen-Barak O; Shachaf C; Ravel Y; Yalon-Hacohen M; Mills GB; Tzukerman M; Skorecki KL
    Cancer Res; 2001 Jul; 61(14):5529-36. PubMed ID: 11454703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping the methylation pattern by bisulfite genomic sequencing of the E-cadherin promoter CpG island in nasopharyngeal carcinoma.
    Kao RH; Huang LC; Hsu YH
    Anticancer Res; 2002; 22(6C):4109-13. PubMed ID: 12553040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upstream stimulatory factor regulates E box-dependent PAI-1 transcription in human epidermal keratinocytes.
    Allen RR; Qi L; Higgins PJ
    J Cell Physiol; 2005 Apr; 203(1):156-65. PubMed ID: 15372465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TAL-1/SCL and its partners E47 and LMO2 up-regulate VE-cadherin expression in endothelial cells.
    Deleuze V; Chalhoub E; El-Hajj R; Dohet C; Le Clech M; Couraud PO; Huber P; Mathieu D
    Mol Cell Biol; 2007 Apr; 27(7):2687-97. PubMed ID: 17242194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Constitutive expression of the Id-1 promoter in human metastatic breast cancer cells is linked with the loss of NF-1/Rb/HDAC-1 transcription repressor complex.
    Singh J; Murata K; Itahana Y; Desprez PY
    Oncogene; 2002 Mar; 21(12):1812-22. PubMed ID: 11896613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutant E-cadherin breast cancer cells do not display constitutive Wnt signaling.
    van de Wetering M; Barker N; Harkes IC; van der Heyden M; Dijk NJ; Hollestelle A; Klijn JG; Clevers H; Schutte M
    Cancer Res; 2001 Jan; 61(1):278-84. PubMed ID: 11196175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The UV responsive elements in the human mimecan promoter: a functional characterization.
    Tasheva ES; Conrad GW
    Mol Vis; 2003 Jan; 9():1-9. PubMed ID: 12533723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter.
    Lim SO; Gu JM; Kim MS; Kim HS; Park YN; Park CK; Cho JW; Park YM; Jung G
    Gastroenterology; 2008 Dec; 135(6):2128-40, 2140.e1-8. PubMed ID: 18801366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of E-cadherin-dependent and -independent events in a new model of c-Fos-mediated epithelial-mesenchymal transition.
    Mejlvang J; Kriajevska M; Berditchevski F; Bronstein I; Lukanidin EM; Pringle JH; Mellon JK; Tulchinsky EM
    Exp Cell Res; 2007 Jan; 313(2):380-93. PubMed ID: 17141758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opposite transcriptional activity between the wild type c-myc gene coding for c-Myc1 and c-Myc2 proteins and c-Myc1 and c-Myc2 separately.
    Batsché E; Crémisi C
    Oncogene; 1999 Oct; 18(41):5662-71. PubMed ID: 10523846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B virus X protein represses E-cadherin expression via activation of DNA methyltransferase 1.
    Lee JO; Kwun HJ; Jung JK; Choi KH; Min DS; Jang KL
    Oncogene; 2005 Oct; 24(44):6617-25. PubMed ID: 16007161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered expression of E-cadherin in hepatocellular carcinoma: correlations with genetic alterations, beta-catenin expression, and clinical features.
    Wei Y; Van Nhieu JT; Prigent S; Srivatanakul P; Tiollais P; Buendia MA
    Hepatology; 2002 Sep; 36(3):692-701. PubMed ID: 12198663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tbx3 represses E-cadherin expression and enhances melanoma invasiveness.
    Rodriguez M; Aladowicz E; Lanfrancone L; Goding CR
    Cancer Res; 2008 Oct; 68(19):7872-81. PubMed ID: 18829543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.